Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunctionRNA polymerase II transcription regulatory region sequence-specific DNA binding

ZNF823 ZNF717 ZNF135 HNF1A USF3 ZBTB33 ZNF585A RBBP4 TET1 ZNF347 FOXJ3 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

2.68e-0514597617GO:0000977
GeneOntologyMolecularFunction5-methylcytosine dioxygenase activity

TET2 TET1

4.28e-053762GO:0070579
GeneOntologyMolecularFunctionRNA polymerase II cis-regulatory region sequence-specific DNA binding

ZNF717 ZNF135 HNF1A ZBTB33 ZNF585A RBBP4 TET1 ZNF347 FOXJ3 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

5.91e-0512447615GO:0000978
GeneOntologyMolecularFunctionDNA-binding transcription factor activity, RNA polymerase II-specific

ZNF823 RLF ZNF717 ZNF135 HNF1A USF3 ZBTB33 ZNF585A ZNF347 FOXJ3 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

6.76e-0514127616GO:0000981
GeneOntologyMolecularFunctioncis-regulatory region sequence-specific DNA binding

ZNF717 ZNF135 HNF1A ZBTB33 ZNF585A RBBP4 TET1 ZNF347 FOXJ3 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

7.54e-0512717615GO:0000987
GeneOntologyMolecularFunctionprotein serine/threonine kinase activity

MARK3 CAMK4 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

2.91e-04446768GO:0004674
GeneOntologyMolecularFunctionprotein kinase activity

MARK3 CAMK4 NTRK2 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

4.46e-04600769GO:0004672
GeneOntologyMolecularFunctionprotein serine kinase activity

MARK3 CAMK4 DCLK3 PSKH2 NLK MAP3K3 CDC7

4.62e-04363767GO:0106310
GeneOntologyMolecularFunctionphosphotransferase activity, alcohol group as acceptor

MARK3 CAMK4 NTRK2 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

1.45e-03709769GO:0016773
DomainTet_JBP

TET2 TET1

1.63e-052762PF12851
Domain2OGFeDO_noxygenase_dom

TET2 TET1

1.63e-052762IPR024779
DomainPP1-bd

CDCA2 MKI67

1.63e-052762IPR029334
DomainPP1_bind

CDCA2 MKI67

1.63e-052762PF15276
DomainTet_JBP

TET2 TET1

1.63e-052762SM01333
Domain-

ZNF823 RLF ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

1.78e-0567976123.30.160.60
Domainzf-C2H2

ZNF823 RLF ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

2.18e-056937612PF00096
DomainZnf_C2H2/integrase_DNA-bd

ZNF823 RLF ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

2.21e-056947612IPR013087
DomainZINC_FINGER_C2H2_2

ZNF823 RLF ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

6.46e-057757612PS50157
DomainZINC_FINGER_C2H2_1

ZNF823 RLF ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

6.62e-057777612PS00028
DomainZnf_C2H2-like

ZNF823 RLF ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

8.33e-057967612IPR015880
DomainZnf_C2H2

ZNF823 RLF ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

9.27e-058057612IPR007087
DomainZnF_C2H2

ZNF823 RLF ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

9.61e-058087612SM00355
DomainPROTEIN_KINASE_ATP

MARK3 CAMK4 NTRK2 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

1.00e-04459769PS00107
DomainSer/Thr_kinase_AS

MARK3 CAMK4 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

1.00e-04357768IPR008271
DomainKRAB

ZNF823 ZNF135 ZNF585A ZNF347 ZNF181 ZNF551 ZNF585B ZNF114

1.02e-04358768PS50805
DomainKRAB

ZNF823 ZNF135 ZNF585A ZNF347 ZNF181 ZNF551 ZNF585B ZNF114

1.02e-04358768PF01352
DomainS_TKc

MARK3 CAMK4 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

1.04e-04359768SM00220
DomainPROTEIN_KINASE_ST

MARK3 CAMK4 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

1.10e-04362768PS00108
DomainKRAB

ZNF823 ZNF135 ZNF585A ZNF347 ZNF181 ZNF551 ZNF585B ZNF114

1.26e-04369768SM00349
DomainKRAB

ZNF823 ZNF135 ZNF585A ZNF347 ZNF181 ZNF551 ZNF585B ZNF114

1.28e-04370768IPR001909
DomainProtein_kinase_ATP_BS

MARK3 CAMK4 NTRK2 GRK5 DCLK3 PSKH2 NLK CDC7

1.51e-04379768IPR017441
DomainPkinase

MARK3 CAMK4 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

1.57e-04381768PF00069
DomainProt_kinase_dom

MARK3 CAMK4 NTRK2 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

1.61e-04489769IPR000719
DomainPROTEIN_KINASE_DOM

MARK3 CAMK4 NTRK2 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

1.72e-04493769PS50011
DomainCa/CaM-dep_Ca-dep_prot_Kinase

MARK3 CAMK4 DCLK3 PSKH2

1.79e-0469764IPR020636
DomainKinase-like_dom

MARK3 CAMK4 NTRK2 GRK5 DCLK3 PSKH2 NLK MAP3K3 CDC7

3.46e-04542769IPR011009
DomainZnF_BED

ZNF415 ZNF181

8.78e-0411762SM00614
DomainZnf_BED

ZNF415 ZNF181

1.05e-0312762IPR003656
Domainzf-C2H2_6

ZNF823 ZNF135 ZNF181 ZNF551 ZNF114 ZNF646

1.75e-03314766PF13912
DomainSEA

MUC16 MUC12

3.58e-0322762PF01390
DomainSEA

MUC16 MUC12

3.91e-0323762PS50024
DomainSEA_dom

MUC16 MUC12

3.91e-0323762IPR000082
Pubmed

A central chaperone-like role for 14-3-3 proteins in human cells.

CEP350 CDCA2 ARFGEF3 TET2 SHROOM3 ALMS1 MARK3 PRRC2C KIAA1217 COBLL1 TET1 RBM7 ANKRD11 MAP3K3

8.20e-09861791436931259
Pubmed

Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.

TET2 SHROOM3 MARK3 KIAA1217 TET1 ANKRD11 TACC2 NHEJ1 FOXJ3 FBXL3

3.87e-07536791015840001
Pubmed

Exchangeable gene trap using the Cre/mutated lox system.

TET2 SHROOM3 MARK3 KIAA1217 TET1 ANKRD11 TACC2 NHEJ1 FOXJ3 FBXL3

4.00e-07538791010512203
Pubmed

Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.

ARFGEF3 CWF19L2 GPBP1L1 ALMS1 RBBP4 PRRC2C KIAA1217 TACC2 UBN2 CDC7

8.95e-07588791038580884
Pubmed

Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.

RLF ARFGEF3 SHROOM3 USF3 EFNA1 RBBP4 MARK3 SCAF8 KIAA1217 PTDSS1 ANKRD11 UBN2 FOXJ3 RIC1 NLK

1.13e-061489791528611215
Pubmed

Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.

CEP350 HBS1L USF3 ALMS1 COBLL1 ZNF347 PTDSS1 UBN2 RIC1

1.84e-0649379915368895
Pubmed

Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.

HBS1L SCAF8 PRRC2C FOXJ3 CEP164

4.10e-0610479510470851
Pubmed

DNA dioxygenases Tet2/3 regulate gene promoter accessibility and chromatin topology in lineage-specific loci to control epithelial differentiation.

TET2 TET1 MKI67

5.03e-061579336630508
Pubmed

Distributive Processing by the Iron(II)/α-Ketoglutarate-Dependent Catalytic Domains of the TET Enzymes Is Consistent with Epigenetic Roles for Oxidized 5-Methylcytosine Bases.

TET2 TET1

5.09e-06279227362828
Pubmed

Structural insight into substrate preference for TET-mediated oxidation.

TET2 TET1

5.09e-06279226524525
Pubmed

Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors.

TET2 TET1

5.09e-06279230045709
Pubmed

Iron-inhibited autophagy via transcription factor ZFP27 in Parkinson's disease.

ZNF585A ZNF585B

5.09e-06279237668106
Pubmed

Stage-specific roles for tet1 and tet2 in DNA demethylation in primordial germ cells.

TET2 TET1

5.09e-06279223415914
Pubmed

Ten-Eleven Translocation Proteins Modulate the Response to Environmental Stress in Mice.

TET2 TET1

5.09e-06279230540950
Pubmed

Tet1 Deficiency Leads to Premature Reproductive Aging by Reducing Spermatogonia Stem Cells and Germ Cell Differentiation.

TET2 TET1

5.09e-06279232114381
Pubmed

Expression of Ki-67 and CD34 on blood and bone marrow cells of CML patients with different response to imatinib and nilotinib therapy.

CD34 MKI67

5.09e-06279232602293
Pubmed

Early Expression of Tet1 and Tet2 in Mouse Zygotes Altered DNA Methylation Status and Affected Embryonic Development.

TET2 TET1

5.09e-06279235955629
Pubmed

Cep164, a novel centriole appendage protein required for primary cilium formation.

ALMS1 CEP164

5.09e-06279217954613
Pubmed

Redox-active quinones induces genome-wide DNA methylation changes by an iron-mediated and Tet-dependent mechanism.

TET2 TET1

5.09e-06279224214992
Pubmed

A kinome screen reveals that Nemo-like kinase is a key suppressor of hepatic gluconeogenesis.

SHROOM3 NLK

5.09e-06279233951476
Pubmed

Distinct roles of the methylcytosine oxidases Tet1 and Tet2 in mouse embryonic stem cells.

TET2 TET1

5.09e-06279224474761
Pubmed

Expression of tyrosine kinase receptor B in eutopic endometrium of women with adenomyosis.

NTRK2 MUC16

5.09e-06279221079983
Pubmed

Ten-eleven translocation protein 1 modulates medulloblastoma progression.

TET2 TET1

5.09e-06279233926529
Pubmed

Coordination of engineered factors with TET1/2 promotes early-stage epigenetic modification during somatic cell reprogramming.

TET2 TET1

5.09e-06279224672749
Pubmed

A primary role of TET proteins in establishment and maintenance of De Novo bivalency at CpG islands.

TET2 TET1

5.09e-06279227288448
Pubmed

Specific functions of TET1 and TET2 in regulating mesenchymal cell lineage determination.

TET2 TET1

5.09e-06279230606231
Pubmed

Ten-eleven translocation 2 modulates allergic inflammation by 5-hydroxymethylcytosine remodeling of immunologic pathways.

TET2 TET1

5.09e-06279234165552
Pubmed

Tet1 and Tet2 Protect DNA Methylation Canyons against Hypermethylation.

TET2 TET1

5.09e-06279226598602
Pubmed

Combined Loss of Tet1 and Tet2 Promotes B Cell, but Not Myeloid Malignancies, in Mice.

TET2 TET1

5.09e-06279226586431
Pubmed

Flanking sequences influence the activity of TET1 and TET2 methylcytosine dioxygenases and affect genomic 5hmC patterns.

TET2 TET1

5.09e-06279235075236
Pubmed

Tet-mediated imprinting erasure in H19 locus following reprogramming of spermatogonial stem cells to induced pluripotent stem cells.

TET2 TET1

5.09e-06279226328763
Pubmed

Ten-Eleven Translocation 1 and 2 Confer Overlapping Transcriptional Programs for the Proliferation of Cultured Adult Neural Stem Cells.

TET2 TET1

5.09e-06279227778125
Pubmed

Immunohistochemical analysis revealed CD34 and Ki67 protein expression as significant prognostic factors in colorectal cancer.

CD34 MKI67

5.09e-06279219340613
Pubmed

Down-regulation of TET2 in CD3⁺ and CD34⁺ cells of myelodysplastic syndromes and enhances CD34⁺ cells proliferation.

TET2 CD34

5.09e-06279226617797
Pubmed

TET-dependent regulation of retrotransposable elements in mouse embryonic stem cells.

TET2 TET1

5.09e-06279227863519
Pubmed

Metabolic control of TH17 and induced Treg cell balance by an epigenetic mechanism.

TET2 TET1

5.09e-06279228783731
Pubmed

Novel Epigenetic Controlling of Hypoxia Pathway Related to Overexpression and Promoter Hypomethylation of TET1 and TET2 in RPE Cells.

TET2 TET1

5.09e-06279228252217
Pubmed

Expression of TET and 5-HmC in Trophoblast Villi of Women with Normal Pregnancy and with Early Pregnancy Loss.

TET2 TET1

1.53e-05379230074219
Pubmed

Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter.

TET2 TET1

1.53e-05379224194590
Pubmed

PRDM14 maintains pluripotency of embryonic stem cells through TET-mediated active DNA demethylation.

TET2 TET1

1.53e-05379226325469
Pubmed

TET proteins in malignant hematopoiesis.

TET2 TET1

1.53e-05379219923888
Pubmed

Rinf Regulates Pluripotency Network Genes and Tet Enzymes in Embryonic Stem Cells.

TET2 TET1

1.53e-05379231433977
Pubmed

Epigenomic analysis of gastrulation identifies a unique chromatin state for primed pluripotency.

TET2 TET1

1.53e-05379231844322
Pubmed

Selective targeting of TET catalytic domain promotes somatic cell reprogramming.

TET2 TET1

1.53e-05379232024762
Pubmed

Tet Enzymes Regulate Telomere Maintenance and Chromosomal Stability of Mouse ESCs.

TET2 TET1

1.53e-05379227184841
Pubmed

Predicting Lymph Node Metastasis in Endometrial Cancer Using Serum CA125 Combined with Immunohistochemical Markers PR and Ki67, and a Comparison with Other Prediction Models.

MKI67 MUC16

1.53e-05379227163153
Pubmed

Tet oxidizes thymine to 5-hydroxymethyluracil in mouse embryonic stem cell DNA.

TET2 TET1

1.53e-05379224838012
Pubmed

Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.

TET2 TET1

1.53e-05379221778364
Pubmed

Tet family proteins and 5-hydroxymethylcytosine in development and disease.

TET2 TET1

1.53e-05379222569552
Pubmed

The Ki-67 and RepoMan mitotic phosphatases assemble via an identical, yet novel mechanism.

CDCA2 MKI67

1.53e-05379227572260
Pubmed

Epigenetic Modifications in the Biology of Nonalcoholic Fatty Liver Disease: The Role of DNA Hydroxymethylation and TET Proteins.

TET2 TET1

1.53e-05379226356709
Pubmed

Pluripotency transcription factors and Tet1/2 maintain Brd4-independent stem cell identity.

TET2 TET1

1.53e-05379229662175
Pubmed

A novel epigenetic marker, Ten-eleven translocation family member 2 (TET2), is identified in the intractable epileptic brain and regulates ATP binding cassette subfamily B member 1 (ABCB1) in the blood-brain barrier.

TET2 TET1

1.53e-05379235235761
Pubmed

One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering.

TET2 TET1

1.53e-05379223992847
Pubmed

Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1.

TET2 TET1

1.53e-05379219372391
Pubmed

Human gallbladder carcinoma: Role of neurotrophins, MIB-1, CD34 and CA15-3.

CD34 MKI67

1.53e-05379220353905
Pubmed

Inhibition of Tet1- and Tet2-mediated DNA demethylation promotes immunomodulation of periodontal ligament stem cells.

TET2 TET1

1.53e-05379231611558
Pubmed

Immunohistochemical study of osteopontin, Ki-67, and CD34 of psoriasis in Mansoura, Egypt.

CD34 MKI67

1.53e-05379222499302
Pubmed

The histone deacetylase SIRT6 controls embryonic stem cell fate via TET-mediated production of 5-hydroxymethylcytosine.

TET2 TET1

1.53e-05379225915124
Pubmed

Differential Expression of MUC12, MUC16, and MUC20 in Patients with Active and Remission Ulcerative Colitis.

MUC16 MUC12

1.53e-05379226770020
Pubmed

Mechanisms of TET protein-mediated DNA demethylation and its role in the regulation of mouse development.

TET2 TET1

1.53e-05379225608811
Pubmed

Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies.

TET2 TET1

1.53e-05379219420352
Pubmed

Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.

TET2 TET1

1.53e-05379228218476
Pubmed

Ascorbate induces ten-eleven translocation (Tet) methylcytosine dioxygenase-mediated generation of 5-hydroxymethylcytosine.

TET2 TET1

1.53e-05379223548903
Pubmed

Mechanisms of resistance in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors.

CD34 MKI67

1.53e-05379225879558
Pubmed

MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.

TET2 TET1

1.53e-05379231266538
Pubmed

5-Hydroxymethylcytosine-mediated active demethylation is required for mammalian neuronal differentiation and function.

TET2 TET1

1.53e-05379234919053
Pubmed

Distinct and overlapping control of 5-methylcytosine and 5-hydroxymethylcytosine by the TET proteins in human cancer cells.

TET2 TET1

1.53e-05379224958354
Pubmed

TrkB and TrkC agonist antibodies improve function, electrophysiologic and pathologic features in Trembler J mice.

PMP22 NTRK2

1.53e-05379220553714
Pubmed

One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering.

TET2 TET1

1.53e-05379223643243
Pubmed

Genome-wide analysis of copy-number variation in humans with cleft lip and/or cleft palate identifies COBLL1, RIC1, and ARHGEF38 as clefting genes.

COBLL1 RIC1

1.53e-05379236493769
Pubmed

Stage-specific regulation of DNA methylation by TET enzymes during human cardiac differentiation.

TET2 TET1

1.53e-05379234879277
Pubmed

Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development.

TET2 TET1

1.53e-05379223352810
Pubmed

Oxygen regulation of TET enzymes.

TET2 TET1

1.53e-05379233410283
Pubmed

Clinicopathological significance of overexpression of TSPAN1, Ki67 and CD34 in gastric carcinoma.

CD34 MKI67

1.53e-05379218822690
Pubmed

Immunohistochemical study of Ki67, CD34 and p53 expression in human tooth buds.

CD34 MKI67

1.53e-05379224715164
Pubmed

Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development.

TET2 TET1

1.53e-05379221816367
Pubmed

Effect of aging on 5-hydroxymethylcytosine in brain mitochondria.

TET2 TET1

1.53e-05379222445327
Pubmed

IGF2BP1 expression in human mesenchymal stem cells significantly affects their proliferation and is under the epigenetic control of TET1/2 demethylases.

TET2 TET1

1.53e-05379224915579
Pubmed

TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing.

TET2 TET1

1.53e-05379226711177
Pubmed

miR-543 regulates the epigenetic landscape of myelofibrosis by targeting TET1 and TET2.

TET2 TET1

1.53e-05379231941838
Pubmed

TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23).

TET2 TET1

1.53e-05379212646957
Pubmed

Loss of Tet enzymes compromises proper differentiation of embryonic stem cells.

TET2 TET1

1.53e-05379224735881
Pubmed

PRDM14 promotes active DNA demethylation through the ten-eleven translocation (TET)-mediated base excision repair pathway in embryonic stem cells.

TET2 TET1

1.53e-05379224335252
Pubmed

Differential expression of ten-eleven translocation genes in endometrial cancers.

TET2 TET1

1.53e-05379228349832
Pubmed

Zfp281 Coordinates Opposing Functions of Tet1 and Tet2 in Pluripotent States.

TET2 TET1

1.53e-05379227345836
Pubmed

The immunoexpression of CD34, Bcl-2, and Ki-67 antigens in sinonasal inverted papillomas.

CD34 MKI67

1.53e-05379224717877
Pubmed

Different roles for Tet1 and Tet2 proteins in reprogramming-mediated erasure of imprints induced by EGC fusion.

TET2 TET1

1.53e-05379223453809
Pubmed

Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification.

TET2 TET1

1.53e-05379220639862
Pubmed

Ten-Eleven Translocation Genes are Downregulated in Endometriosis.

TET2 TET1

1.53e-05379226917261
Pubmed

Alternation of ten-eleven translocation 1, 2, and 3 expression in eutopic endometrium of women with endometriosis-associated infertility.

TET2 TET1

1.53e-05379230130982
Pubmed

Regulation of DNA methylation signatures on NF-κB and STAT3 pathway genes and TET activity in cigarette smoke extract-challenged cells/COPD exacerbation model in vitro.

TET2 TET1

1.53e-05379232342329
Pubmed

Interaction network of human early embryonic transcription factors.

RLF TET2 ALMS1 TET1 MKI67 BCL9 UBN2

1.56e-0535179738297188
Pubmed

Human transcription factor protein interaction networks.

RLF CDCA2 TET2 FLG HNF1A ZBTB33 ALMS1 SCAF8 PRRC2C MKI67 HERC1 BCL9 UBN2

1.90e-051429791335140242
Pubmed

The Eyes Absent family members EYA4 and EYA1 promote PLK1 activation and successful mitosis through tyrosine dephosphorylation.

TET2 ALMS1 BCL9 UBN2 FOXJ3

2.59e-0515279538360978
Pubmed

Proteomic characterization of the human centrosome by protein correlation profiling.

CEP350 ALMS1 CEP164

2.82e-052679314654843
Pubmed

Tet-mediated DNA demethylation regulates specification of hematopoietic stem and progenitor cells during mammalian embryogenesis.

TET2 TET1

3.05e-05479235235365
Pubmed

[DNA hypomethylation in villi of patients with unexplained recurrent spontaneous abortion and its mechanism].

TET2 TET1

3.05e-05479231167695
Pubmed

Reprogramming of the paternal genome upon fertilization involves genome-wide oxidation of 5-methylcytosine.

TET2 TET1

3.05e-05479221321204
Pubmed

Paradoxical association of TET loss of function with genome-wide DNA hypomethylation.

TET2 TET1

3.05e-05479231371502
InteractionYWHAH interactions

CEP350 CDCA2 ARFGEF3 TET2 SHROOM3 GPBP1L1 ALMS1 MARK3 PRRC2C KIAA1217 COBLL1 TET1 RBM7 ANKRD11 HERC1 MAP3K3

2.78e-0611027616int:YWHAH
InteractionYWHAG interactions

CEP350 CDCA2 TET2 HNF1A SHROOM3 GPBP1L1 ZBTB33 ALMS1 MARK3 PRRC2C COBLL1 GRK5 TET1 RBM7 ANKRD11 MAP3K3

1.35e-0512487616int:YWHAG
CytobandEnsembl 112 genes in cytogenetic band chr10q26

GRK5 MKI67 TACC2 ADAM8

4.63e-04207794chr10q26
Cytoband3p22.2

SCN10A DCLK3

7.87e-04247923p22.2
CytobandEnsembl 112 genes in cytogenetic band chr19q13

ZNF135 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114

1.03e-031192798chr19q13
Cytoband6q23.3

ARFGEF3 HBS1L

1.07e-03287926q23.3
GeneFamilyZinc fingers C2H2-type|ZF class homeoboxes and pseudogenes

ZNF823 RLF ZNF717 ZNF135 ZBTB33 ZNF585A ZNF347 ZNF415 ZNF181 ZNF551 ZNF585B ZNF114 ZNF646

1.24e-08718451328
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

CDCA2 ARFGEF3 ZFYVE16 RBM26 MKI67

8.40e-05181455694
GeneFamilyCD molecules|Mucins

MUC16 MUC12

1.23e-0321452648
CoexpressionGSE13738_RESTING_VS_BYSTANDER_ACTIVATED_CD4_TCELL_UP

CAMK4 RBM26 HERC1 BCL9 UBN2 FOXJ3 FBXL3

1.85e-06194787M3321
CoexpressionGSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN

CEP350 TET2 ZFYVE16 SNX29P2 ADAM8 ZNF585B

2.51e-05194786M7306
CoexpressionGSE10240_CTRL_VS_IL22_STIM_PRIMARY_BRONCHIAL_EPITHELIAL_CELLS_UP

CEP350 CD34 TET1 RBM26 CARD6 TACC2

2.98e-05200786M302
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#5_top-relative-expression-ranked_500

RLF RBBP4 PRRC2C KIAA1217 TET1 ANKRD11 HERC1

1.01e-06150757gudmap_developingGonad_e12.5_epididymis_k5_500
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000

HEG1 RBBP4 PRRC2C NTRK2 KIAA1217 COBLL1 TET1 ANKRD11

6.67e-06281758gudmap_developingGonad_e18.5_epididymis_1000_k3
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500

RLF HEG1 RBBP4 PRRC2C KIAA1217 TET1 RBM26 ANKRD11 HERC1

1.29e-05406759gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500

RLF HEG1 RBBP4 PRRC2C KIAA1217 TET1 RBM26 ANKRD11 HERC1

1.48e-05413759gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000

RLF HEG1 RBBP4 PRRC2C NTRK2 KIAA1217 COBLL1 TET1 RBM26 DCLK3 ANKRD11 HERC1

2.19e-057997512gudmap_developingGonad_e18.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_top-relative-expression-ranked_1000

RLF CDCA2 CWF19L2 HEG1 RBBP4 PRRC2C KIAA1217 TET1 RBM26 ANKRD11 HERC1 ADAM8

2.33e-058047512gudmap_developingGonad_e12.5_ovary_1000
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_500

HEG1 RBBP4 PRRC2C KIAA1217 TET1 ANKRD11

2.34e-05162756gudmap_developingGonad_e16.5_epididymis_500_k2
CoexpressionAtlasDevelopingGonad_e12.5_ovary_emap-28876_k-means-cluster#3_top-relative-expression-ranked_1000

CDCA2 HEG1 RBBP4 PRRC2C KIAA1217 TET1 ANKRD11

5.55e-05277757gudmap_developingGonad_e12.5_ovary_k3_1000
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500

RLF RBBP4 PRRC2C KIAA1217 TET1 RBM26 ANKRD11 HERC1

8.73e-05403758gudmap_developingGonad_e12.5_epididymis_500
CoexpressionAtlasfacebase_RNAseq_e10.5_MaxArch_2500_K3

ZNF823 CDCA2 TET2 CWF19L2 HEG1 ZBTB33 ZNF585A ALMS1 CAMK4 TET1 RBM26 MKI67 BCL9 RIC1

1.08e-0412527514facebase_RNAseq_e10.5_MaxArch_2500_K3
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500_K3

ZNF823 CEP350 CDCA2 CWF19L2 HEG1 ZBTB33 ALMS1 MARK3 TET1 RBM26 MKI67 BCL9 NHEJ1 UBN2

1.13e-0412577514facebase_RNAseq_e10.5_Emin_LatNas_2500_K3
CoexpressionAtlasFacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#5

CEP350 CDCA2 TET2 CWF19L2 ALMS1 RSPH4A NTRK2 PCLO MAMLD1 NCKAP5

1.48e-046887510Facebase_RNAseq_e10.5_Mandibular Arch_2500_K5
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5

CWF19L2 HEG1 ALMS1 RNF103 NTRK2 PCLO MAMLD1 MKI67 NCKAP5 FBXL3 CEP164

1.53e-048317511Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5
CoexpressionAtlasalpha beta T cells, T.8Nve.PP, TCRb+ CD8+ CD44low CD62L high, Peyer's Patch, avg-1

CEP350 CAMK4 PRRC2C TET1 CARD6 HERC1 NLK

1.84e-04336757GSM538413_500
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000

HEG1 RBBP4 PRRC2C COBLL1 TET1 ANKRD11

2.51e-04249756gudmap_developingGonad_P2_epididymis_1000_k3
CoexpressionAtlasgamma delta T cells, Tgd.vg2+24ahi.Th, TCRd+ Vg2+ CD24+, Thymus, avg-3

HEG1 CAMK4 TET1 MKI67

2.56e-0487754GSM476655_100
CoexpressionAtlasDevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000

CDCA2 RBBP4 PRRC2C KIAA1217 TET1 ANKRD11

3.10e-04259756gudmap_developingGonad_e12.5_epididymis_k3_1000
CoexpressionAtlasDevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_500

RBBP4 PRRC2C KIAA1217 TET1 ANKRD11

3.89e-04175755gudmap_developingGonad_e14.5_ epididymis_500_k4
CoexpressionAtlasdev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000

PMP22 ZNF823 TET2 KIAA1217 GRK5 TET1 MKI67 MUC16 PALMD BCL9

3.92e-047777510gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000

RLF CDCA2 HEG1 RBBP4 PRRC2C KIAA1217 TET1 RBM26 ANKRD11 HERC1

4.47e-047907510gudmap_developingGonad_e16.5_epididymis_1000
CoexpressionAtlasDevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000

RLF HEG1 RBBP4 PRRC2C CD34 COBLL1 TET1 DCLK3 ANKRD11 HERC1

4.79e-047977510gudmap_developingGonad_P2_epididymis_1000
CoexpressionAtlasDevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#2_top-relative-expression-ranked_1000

CDCA2 RBBP4 PRRC2C KIAA1217 TET1 ANKRD11

5.05e-04284756gudmap_developingGonad_e16.5_epididymis_1000_k2
CoexpressionAtlasfacebase_RNAseq_e10.5_Emin_LatNas_2500

ZNF823 CEP350 CDCA2 CWF19L2 HEG1 ZBTB33 ALMS1 MARK3 TET1 RBM26 MKI67 BCL9 NHEJ1 UBN2

5.23e-0414597514facebase_RNAseq_e10.5_Emin_LatNas_2500
CoexpressionAtlasDevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500

RLF HEG1 RBBP4 PRRC2C TET1 RBM26 HERC1

5.59e-04404757gudmap_developingGonad_e18.5_epididymis_500
CoexpressionAtlasB cells, proB.CLP.BM, CD19- IgM- CD43+ CD24- AA4.1+ CD45R- CD117+ IL7R+, Bone marrow, avg-1

CDCA2 CYP2J2 CD34 COBLL1 TET1 MKI67 ADAM8

5.67e-04405757GSM538343_500
CoexpressionAtlasFacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3

RLF CDCA2 CWF19L2 ALMS1 PRRC2C NTRK2 PCLO ANKRD11

5.70e-04532758Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3
CoexpressionAtlasFacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#4

CWF19L2 ALMS1 NTRK2 PCLO MAMLD1 NCKAP5

6.50e-04298756Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K4
ToppCellwk_20-22-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

HEG1 EFNA1 NTRK2 CD34 COBLL1 NCKAP5 PALMD

5.25e-08195787a432d69b0172211ee4d53675936a1dc9ce1ae1f0
ToppCellControl-Epithelial-Club|World / Disease state, Lineage and Cell class

ARFGEF3 SHROOM3 EFNA1 KIAA1217 NCKAP5 TACC2

9.24e-071867869798428691408e17ff2af2fe2d1b345f074d67e4
ToppCellCOPD-Epithelial-Club|World / Disease state, Lineage and Cell class

ARFGEF3 SHROOM3 EFNA1 KIAA1217 NCKAP5 TACC2

9.24e-071867863006f4ab1eaf1eb34c10ca9f7c869603d2d25744
ToppCellPCW_07-8.5-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

EFNA1 NTRK2 CD34 COBLL1 CARD6 PALMD

9.53e-07187786106f50ad85a92403037214f0e94702230284837f
ToppCellwk_08-11-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_08-11 / Celltypes from embryonic and fetal-stage human lung

HEG1 EFNA1 NTRK2 CD34 COBLL1 PALMD

9.53e-07187786a27aa97aa6508a3ffe92c2b6bb0511a95650a390
ToppCellwk_15-18-Endothelial-Blood_vessel_endothelial-GRIA2+_arterial_endo|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

HEG1 EFNA1 CD34 COBLL1 NCKAP5 PALMD

9.83e-07188786366a2d59b9c81d8a7659749f9c07efa46b49a39a
ToppCellCOPD-Epithelial-Club|COPD / Disease state, Lineage and Cell class

ARFGEF3 SHROOM3 EFNA1 KIAA1217 NCKAP5 TACC2

1.08e-06191786c909cf5fa0e6519aa93a47d2c3fcd2ae2163cd8d
ToppCellTCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9

CEP350 ARFGEF3 USF3 ZBTB33 ZFYVE16 BCL9

1.15e-06193786abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCellPCW_07-8.5-Endothelial-Endothelial_mature|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

EFNA1 NTRK2 CD34 COBLL1 CARD6 PALMD

1.18e-061947868c88a0ddd61ad900426e312ca4ab13061c0380b8
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HEG1 EFNA1 NTRK2 CD34 NCKAP5 PALMD

1.18e-061947862c78e754cac848fd47172f94e392749eb0ab50d4
ToppCellPND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HEG1 EFNA1 NTRK2 CD34 NCKAP5 PALMD

1.18e-0619478692a8e6e3e3f6fd9dacb723b58e7a8b63473e403e
ToppCellLPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 KIAA1217 CD34 GRK5 NCKAP5 PALMD

1.18e-061947860b9cd96fa0b616da7cc90e92ff71157e9bba518f
ToppCellPCW_10-12-Endothelial-Endothelial_mature|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ARFGEF3 EFNA1 NTRK2 CD34 COBLL1 PALMD

1.25e-06196786481d79bdaec069ad2746a28d39eeee8d3edf7305
ToppCell(03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition

CEP350 TET2 SHROOM3 PRRC2C PCLO ANKRD11

1.37e-06199786c425e7975f492ed5cfcca022248adb627e1d27d4
ToppCellTracheal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARFGEF3 SHROOM3 KIAA1217 PCLO MUC16 TACC2

1.41e-06200786d3af0a706baf66e3f32e67b17dcfc31e5b32ce0e
ToppCellControl_saline-Endothelial-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

HEG1 KIAA1217 CD34 NCKAP5 PALMD MAPRE2

1.41e-06200786e77eba6172cabf85b8028638ed35299f2f079cd8
ToppCellControl_saline-Endothelial|Control_saline / Treatment groups by lineage, cell group, cell type

HEG1 KIAA1217 CD34 NCKAP5 PALMD MAPRE2

1.41e-062007863372c488a39fe812fa94e4f0564594186fea3db5
ToppCellClub_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id

ARFGEF3 SHROOM3 CYP2J2 NCKAP5 ZNF415

8.87e-06159785a7bcff268b1962a561fd2848e01ae16565bce895
ToppCellControl|World / group, cell type (main and fine annotations)

ARFGEF3 SHROOM3 COBLL1 NCKAP5 TACC2

1.16e-05168785a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6
ToppCell5'-GW_trimst-2-LargeIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

GALNT15 CD34 MKI67 PALMD MAP3K3

1.53e-05178785ea10117026021c959ffc871fc377cdb3e161d264
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2/Club-like_(AT2/Club-like)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 EFNA1 KIAA1217 TACC2

1.53e-05178785f5ed4a6e3eb8056b1be1fb311021710c95bdf888
ToppCellChildren_(3_yrs)-Epithelial-club_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 CYP2J2 KIAA1217 NCKAP5

1.70e-05182785215c303df42f13597b2c7a95cb157c6bc7aca9a1
ToppCell10x5'v1-week_12-13-Endothelial-stroma-sinusoidal_EC|week_12-13 / cell types per 3 fetal stages;per 3',per 5'

GALNT15 EFNA1 RSPH4A KIAA1217 PALMD

1.89e-05186785e8ead5634686ebaa6a230eea69795d923ce9939d
ToppCelldroplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CEP350 HEG1 EFNA1 PRRC2C PALMD

1.89e-051867850ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCellAdult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 CYP2J2 KIAA1217 NCKAP5

1.94e-05187785ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell__prolif|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

1.94e-0518778535c382c0aabd46906113e5db30ea24bb8e658899
ToppCellCOVID-19-Endothelial_cells-Endothelial_cells_(general)|COVID-19 / group, cell type (main and fine annotations)

NTRK2 KIAA1217 CD34 GRK5 PALMD

2.10e-05190785812e11314c76c0179fbe5a9bea29b41ce5cbc93d
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

GALNT15 CDCA2 CD34 MKI67 CDC7

2.10e-0519078531de1727822e9818652946dfb962daee77ffad68
ToppCellControl-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class

NTRK2 KIAA1217 GRK5 NCKAP5 PALMD

2.10e-051907857f3f419fffe02934b6f27b697f7a6401072491ed
ToppCellPCW_07-8.5-Endothelial-Endothelial_mature-endo_arterial_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung

EFNA1 CD34 COBLL1 CARD6 PALMD

2.10e-051907851307688255a1250fa300edf2c41f1affe31dcc98
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

ARFGEF3 RSPH4A MUC16 TACC2 PALMD

2.15e-051917857b5da29109aa28768c67653a1bc0f385c2d2269b
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ARFGEF3 RSPH4A MUC16 TACC2 PALMD

2.15e-05191785fa9f8b50bfc7911c858bc2f9dcd204873d97ac61
ToppCellChildren_(3_yrs)-Epithelial-club_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 CYP2J2 KIAA1217 NCKAP5

2.15e-0519178523776c7302cead3881b39127398f3b3e0d27885e
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

ARFGEF3 RSPH4A MUC16 TACC2 PALMD

2.15e-05191785b4e335e798c9617356b8e24412f9270c42dce656
ToppCellBAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ARFGEF3 RSPH4A MUC16 TACC2 PALMD

2.15e-05191785c4b223b33c020a064f576711a3d700eb60a2d737
ToppCellChildren_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 KIAA1217 COBLL1 TACC2

2.15e-05191785e432c6e1ae82dddf84314ce73d2b7a991630d905
ToppCellControl-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30）

ARFGEF3 RSPH4A MUC16 TACC2 PALMD

2.15e-05191785cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12
ToppCellControl-Multiplet-Multiplet|World / Disease state, Lineage and Cell class

ARFGEF3 SHROOM3 KIAA1217 COBLL1 TACC2

2.20e-051927851bfd022d5b87cf8a5d5069f559339a553a52a0a2
ToppCellEpithelial|World / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 KIAA1217 COBLL1 TACC2

2.20e-05192785499e8893afea5e6d3371e0bd018f7e86a524d669
ToppCellCOPD-Epithelial|COPD / Disease state, Lineage and Cell class

ARFGEF3 SHROOM3 EFNA1 KIAA1217 TACC2

2.20e-051927850644fad5df18f0021f6f49cca996d8cf47f972ff
ToppCellLPS-IL1RA+antiTNF-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 NTRK2 KIAA1217 CD34 PALMD

2.20e-0519278504f5a2e3dd6beff027b89d66eefdd92036e041af
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 NTRK2 KIAA1217 CD34 PALMD

2.20e-05192785c07d7b40b2aa4eb27ac85801c014a656e2fd01dc
ToppCellChildren_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 COBLL1 PCLO TACC2

2.20e-05192785cc9911e182a289779a2612bc213daae5607689e7
ToppCellAdult-Epithelial|Adult / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 KIAA1217 COBLL1 TACC2

2.20e-05192785efb962a5fd3b9bdfd8cf8d13c435e29c8271713e
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.20e-0519278528eb3a5728e8901bcb5ba12f6b009f41b065fa37
ToppCellLPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 KIAA1217 CD34 NCKAP5 PALMD

2.26e-05193785e09387af84d2a0a526e54d4793e6e06c6739db53
ToppCellLPS-antiTNF-Endothelial-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 NTRK2 KIAA1217 CD34 PALMD

2.26e-0519378502f633b016ab19bfa65bfd0cf32f000549a62148
ToppCellLPS-antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 KIAA1217 CD34 NCKAP5 PALMD

2.26e-051937856e1982d089a9de628e6006d23ff78a223fbd9f47
ToppCellEpithelial-club_cell|World / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 CYP2J2 KIAA1217 NCKAP5

2.26e-051937852bdd09004fa433550958ec42ba4b06271a4aaf7c
ToppCellPCW_10-12-Endothelial-Endothelial_cycling-endo_proliferating1_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ARFGEF3 EFNA1 CD34 MKI67 PALMD

2.26e-05193785643f992dbce639e7d147924d8b8f455fcebf215a
ToppCellLPS-antiTNF-Endothelial|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 NTRK2 KIAA1217 CD34 PALMD

2.26e-051937855122b1ffba42de190061be34ecdc6176f84e56a3
ToppCellLPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 NTRK2 KIAA1217 CD34 COBLL1

2.26e-05193785a3636c35ed25aabe2f1aba016c9fe125327bbfaf
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.26e-051937856a623acd1adad9a78eddc32ffedb16352ad3fdfa
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.26e-05193785287e756d5fd3bd2931c168da24beaa0d02a350ae
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Ascending_Vasa_Recta_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.32e-05194785cf9cf115dbbb9997f7c303ae07f42f3d80ff9a21
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HEG1 NTRK2 CD34 NCKAP5 PALMD

2.32e-051947851b382508453c5b08fb617f626b230adf3b6cff99
ToppCellnucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ARFGEF3 SHROOM3 COBLL1 NCKAP5 TACC2

2.32e-0519478553f3e49e91b1096f3226010e2de767efb490dfe4
ToppCellLPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 NTRK2 KIAA1217 CD34 PALMD

2.32e-0519478543f92b0533e26633dc94cce554045d641ef8fd76
ToppCelldroplet-Lung-1m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

EFNA1 NTRK2 CD34 NCKAP5 PALMD

2.32e-051947851ac52b00ea0b0ddbd04f5d85fa8c086980a78926
ToppCellIPF-Endothelial-VE_Capillary_B|IPF / Disease state, Lineage and Cell class

HEG1 KIAA1217 CD34 NCKAP5 PALMD

2.32e-05194785169a304d5c13f08c39fad4116f093bc4a0765e9d
ToppCellLPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HEG1 NTRK2 KIAA1217 CD34 PALMD

2.32e-051947851d39d968730a7e85b6161c1c8a6bd38afe9bcad7
ToppCellControl-Multiplet|Control / Disease state, Lineage and Cell class

ARFGEF3 SHROOM3 KIAA1217 COBLL1 TACC2

2.37e-05195785618900c80bea09d46dad3f741bd1bff8bf0a64ee
ToppCell10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

GALNT15 EFNA1 RSPH4A KIAA1217 PALMD

2.37e-0519578522a481927147ec4ae9d59e6af7c87df0e9cb51e4
ToppCellControl-Multiplet-Multiplet|Control / Disease state, Lineage and Cell class

ARFGEF3 SHROOM3 KIAA1217 COBLL1 TACC2

2.37e-0519578506ac685855e14e4dd2cbe6d0e73f894f2eeff91f
ToppCellnucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

ARFGEF3 SHROOM3 COBLL1 NCKAP5 TACC2

2.37e-051957859406866f99555198a9be311fbd65751b70f35446
ToppCellBronchial-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARFGEF3 SHROOM3 CYP2J2 KIAA1217 MUC16

2.37e-05195785e7230a849ea31e6eef9bc6f5468938499450582d
ToppCellPND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP1-CAP1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HEG1 NTRK2 CD34 NCKAP5 PALMD

2.37e-05195785cd011433b3b9bfb1adb13eca2f3f2a5db024cd94
ToppCellControl-Epithelial|Control / Disease state, Lineage and Cell class

ARFGEF3 SHROOM3 EFNA1 KIAA1217 TACC2

2.37e-051957851798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa
ToppCellwk_15-18-Endothelial-Blood_vessel_endothelial-Late_cap|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

HEG1 CD34 COBLL1 NCKAP5 PALMD

2.37e-05195785dfc5da514fb34a2c318a5c4c61f44049fa43960e
ToppCellPCW_13-14-Endothelial-Endothelial_mature|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

EFNA1 NTRK2 CD34 COBLL1 PALMD

2.37e-0519578531353269591c9eee84872838e91995d4a035da46
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-051967858ad8efb631164b46f0c082572270188e5ead20bf
ToppCellPCW_10-12-Endothelial-Endothelial_mature-endo_capillary_(2)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

EFNA1 NTRK2 CD34 COBLL1 PALMD

2.43e-051967852a2a93b89dcb98043cb1f8b422ac8c55e2edc37b
ToppCellCOVID-19-kidney-VWF+PLVAP+VCAM1+EC|kidney / Disease (COVID-19 only), tissue and cell type

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-05196785ac2c4a325efa8497a755cd31fb6a9d94d8e3bf42
ToppCellkidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-05196785a20a56d8997d6db2a10046c8801c619a379de83c
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-0519678522767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-05196785b8f89a50114932c08fc5daac4b549adfe9df8e66
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-051967859606ea7e42f707e69ea891b3521037613b9675f5
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-05196785145fcf73deba9638b391a1af6c39fa205dc9829f
ToppCellrenal_medulla_nuclei-CKD+DKD_normotensive-Endothelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-05196785adee900dcd16dbaba15c58bdcace09ba20214950
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Endothelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.43e-05196785d0ff1082898d2db47c88d2678466514e9e9193d3
ToppCell10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

GALNT15 EFNA1 RSPH4A KIAA1217 PALMD

2.49e-051977854e58bbf3ecb30b4c8199adcc04d2eb134d90de56
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.49e-051977850f467ef58f0c4dcc00b34b7b9639e03fb3ebe780
ToppCellCOVID-19-lung-Capillary_1|lung / Disease (COVID-19 only), tissue and cell type

NTRK2 KIAA1217 CD34 GRK5 PALMD

2.49e-051977857e86ff9dafcbaaa7464d61484dd48bfeb7eae6e4
ToppCell10x3'2.3-week_17-19-Endothelial-stroma-tip_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5'

HEG1 EFNA1 KIAA1217 CD34 PALMD

2.49e-05197785b212ff28ca2d1fea4140f186ab90941bdca21249
ToppCellPCW_13-14-Endothelial-Endothelial_cycling-endo_proliferating2_(14)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung

CDCA2 EFNA1 CD34 MKI67 PALMD

2.49e-051977858e655db7c6f04d49927a1f0a75178e5955b4af08
ToppCellwk_20-22-Endothelial-Blood_vessel_endothelial-Late_cap|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

HEG1 EFNA1 CD34 COBLL1 PALMD

2.49e-05197785797ea1c9f75f88b51fdfc17a2b27ed0199ae64c9
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.55e-05198785b027a141ab531d0f5d6a26811a53427e7b0771dd
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARFGEF3 SHROOM3 CYP2J2 KIAA1217 NCKAP5

2.55e-05198785af399569c718f5fd971d73a7926768c9311002a3
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.55e-05198785953630dbe3154b1b102b87de0feca2cbf124eabe
ToppCellParenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Club|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARFGEF3 SHROOM3 CYP2J2 KIAA1217 NCKAP5

2.55e-051987851408e02e053ad3406229bfe8189da03be6366e81
ToppCellrenal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.55e-051987858e45551224fbb30c0658ad47dd98335ecf165437
ToppCellFetal_29-31_weeks-Epithelial-club_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

ARFGEF3 SHROOM3 CYP2J2 KIAA1217 PCLO

2.55e-051987856ba5e5970109a04ed968bac7ff099ae250c579dc
ToppCellBronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARFGEF3 SHROOM3 KIAA1217 COBLL1 TACC2

2.61e-051997855f7da3eab58ace6cddb3179a415cd839d5767958
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)

ARFGEF3 SHROOM3 EFNA1 NCKAP5 TACC2

2.61e-05199785b44d74895846e2ac144438b73e0ca91e3949c16c
ToppCellParenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

ARFGEF3 SHROOM3 KIAA1217 COBLL1 TACC2

2.61e-051997855cea0d9e261903e0eaad60c28a07dff72ce65027
ToppCellLung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)

ARFGEF3 SHROOM3 EFNA1 NCKAP5 TACC2

2.61e-051997854b374a5de82b4614d3d8a00202ea6cb8f1fd8104
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Peritubular_Capilary_Endothelial_Cell_|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.61e-05199785da5a88749d859d535daa030d0974485906cc0ba7
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

PMP22 GALNT15 HEG1 CD34 PALMD

2.61e-05199785f35e9c05d0a0339ff691b38564da7aad8e9218aa
ToppCellParenchyma_Control_(B.)-Epithelial-TX-Transitional_AT2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type

ARFGEF3 SHROOM3 EFNA1 NCKAP5 TACC2

2.61e-051997859e8231c9007d8d963805a4c99e0905538ceb9b60
ToppCellBiopsy_Other_PF-Epithelial-SCGB3A2+_SCGB1A1+|Biopsy_Other_PF / Sample group, Lineage and Cell type

ARFGEF3 SHROOM3 EFNA1 CYP2J2 KIAA1217

2.61e-05199785036244251d2dd39f8184b7095418c723c0524eff
Diseaseresponse to anticoagulant

CAMK4 BCL9 ZNF646

1.45e-0441733GO_0061476
DiseaseVentricular Fibrillation

SCN10A SLC4A3

1.67e-048732C0042510
DiseaseShort Stature, CTCAE

RSPH4A FBXL3

2.68e-0410732C2919142
DiseaseShort stature

RSPH4A FBXL3

2.68e-0410732C0349588
Diseaseserum alanine aminotransferase measurement

GALNT15 HNF1A SHROOM3 EFNA1 MARK3 COBLL1 PCLO TET1 MAPRE2

2.88e-04869739EFO_0004735
DiseaseShortened QT interval

SCN10A SLC4A3

3.27e-0411732C0151879
Diseasecystatin C measurement

HNF1A SHROOM3 ALMS1 SCAF8 KIAA1217 ANKRD11

4.86e-04402736EFO_0004617
Diseasehepcidin:transferrin saturation ratio

MUC16 ZNF551

6.21e-0415732EFO_0007902
DiseaseIntrahepatic cholestasis of pregnancy

HNF1A SHROOM3

7.08e-0416732EFO_0009048
Diseaseinfant expressive language ability

CAMK4 RBM26

7.08e-0416732EFO_0006316
Diseasealcohol consumption measurement

GALNT15 HNF1A ALMS1 MARK3 NTRK2 COBLL1 PCLO ANKRD11 NCKAP5 MAPRE2

9.38e-0412427310EFO_0007878
DiseaseBrugada syndrome

SCN10A MAPRE2

1.00e-0319732MONDO_0015263
Diseaserenal system measurement

SHROOM3 SCAF8

1.11e-0320732EFO_0004742
Diseasekidney disease (biomarker_via_orthology)

HNF1A MKI67

1.23e-0321732DOID:557 (biomarker_via_orthology)
Diseasealbuminuria

SHROOM3 EFNA1 PRRC2C

1.66e-0394733EFO_0004285
DiseaseDwarfism

RSPH4A FBXL3

1.75e-0325732C0013336
Diseaselow density lipoprotein cholesterol measurement, alcohol consumption measurement

HNF1A COBLL1 MAPRE2

1.92e-0399733EFO_0004611, EFO_0007878
Diseasespontaneous preterm birth

PMP22 KIAA1217 NCKAP5

2.03e-03101733EFO_0006917
DiseasePsychotic Disorders

CD34 TET1 BCL9

2.03e-03101733C0033975
Diseasepulse pressure measurement

TET2 CWF19L2 SHROOM3 MARK3 KIAA1217 COBLL1 TET1 SCN10A ANKRD11 CEP164

2.19e-0313927310EFO_0005763
DiseaseChild Development Disorders, Specific

PMP22 NTRK2

2.35e-0329732C0085997
DiseaseChild Development Deviations

PMP22 NTRK2

2.35e-0329732C0085996
Disease1,5 anhydroglucitol measurement

EFNA1 NCKAP5

2.35e-0329732EFO_0008009

Protein segments in the cluster

PeptideGeneStartEntry
VGPHTDKSPQHSSSS

SLC4A3

191

P48751
HGSSAAQKQNPSHTD

ANKRD11

526

Q6UB99
SKHTGNPTSSFHEEN

CYP2J2

286

P51589
GTPTVSSNSHSHSEK

ALMS1

946

Q8TCU4
SSHEQSESTHGQTAP

FLG

1446

P20930
THEQSESTHGQSAPS

FLG

2096

P20930
SPVQSDSSTAKEHGH

FLG

3916

P20930
SHSSGAVNQDHSKNP

ADAM8

311

P78325
TTPSCNSFDGKHQDH

COBLL1

606

Q53SF7
TVIAPTHHGNNTTES

RBM26

256

Q5T8P6
QNPRSSSTHSEHKPS

RIC1

441

Q4ADV7
VSSEENGHSFHTPQK

HBS1L

181

Q9Y450
TNVKANNSGHESHSP

MUC16

5126

Q8WXI7
SEASPHENTNHKSPH

PALMD

486

Q9NP74
PHSQSPGSAQSSKSH

PSKH2

346

Q96QS6
SSHIKSVHSQDPSGD

ZBTB33

566

Q86T24
SPGSHHANGNKLSSV

GPBP1L1

216

Q9HC44
HGSIQESHKASRDPS

CAMK4

346

Q16566
QHSPESSSGSADVHS

HERC1

131

Q15751
KQVSPSSEGHFRSQH

DCLK3

626

Q9C098
HQTVTAQASKHSPEA

GALNT15

41

Q8N3T1
SIDHGKSHSSQSSQQ

PCLO

4831

Q9Y6V0
SNQKPSETSTDEHQH

CWF19L2

431

Q2TBE0
SDSSNGQSHLLPSNH

HNF1A

601

P20823
HSSQTADLKSQSTPH

HEG1

771

Q9ULI3
SGQSTHTHKEPASGD

MKI67

2626

P46013
GSAAAVHPVQQHTSS

NLK

56

Q9UBE8
NTSKPSHSVDAHTAE

RBBP4

261

Q09028
STNPSQAKAHHSKAG

CARD6

1016

Q9BX69
TVSGKITHSPQAHDN

EFNA1

146

P20827
STPKLTSDIQGHASH

CDC7

471

O00311
SENPGQTHFHTIQKS

FBXL3

261

Q9UKT7
HPHSNQSSLSNSHGS

FOXJ3

341

Q9UPW0
NSADHIKSQDSQHTP

BCL9

126

O00512
GQTTPEDHSGNHKNS

ARFGEF3

521

Q5TH69
GAPSNFSSSHLESKH

CEP350

136

Q5VT06
ASSVKPQHQHGNSFT

MAMLD1

651

Q13495
SGIFTNTKESSSHHP

FGA

551

P02671
NTKESSSHHPGIAEF

FGA

556

P02671
HHANSPTAGAAKSSP

MAPRE2

196

Q15555
SDLNNSTGQSPHHKV

MARK3

391

P27448
STGQSPHHKVQRSVS

MARK3

396

P27448
SLHLEKNGNHTPSSS

CDCA2

841

Q69YH5
SPSSKTSFNHHINSN

GRK5

566

P34947
DKQSVLHNSPGTASH

RNF103

556

O00237
EHSASPSQGSSQQHF

SCAF8

341

Q9UPN6
SLHPVSQHGNEATTN

CD34

71

P28906
LSQDRNHNSSSPHSG

MAP3K3

121

Q99759
NHNSSSPHSGVSRQV

MAP3K3

126

Q99759
KSVTSPHTEARQSGH

PCARE

381

A6NGG8
SSDKRESTPHHTSQS

RSPH4A

131

Q5TD94
ESTPHHTSQSEGNTF

RSPH4A

136

Q5TD94
HSESPEKNGAHSVTQ

SNX29P2

216

Q8IUI4
GKVHFTATHPANSNI

SPATA48

371

A4D263
DQSGFSPSVQSHSHS

RBM7

166

Q9Y580
KSAASPHAGQESHTL

TCP10L

106

Q8TDR4
SSSPAKSHNSPHGCQ

NCKAP5

1121

O14513
SHGSNHTQKPDEQRS

PRRC2C

926

Q9Y520
TTANRNHTDSAGTPH

KIAA1217

601

Q5T5P2
NSPHSNERKSTHSNK

SHROOM3

581

Q8TF72
KHQGAGDPHTSNSAS

NHEJ1

231

Q9H9Q4
KPPSSVHNNHGSSLT

TET1

1126

Q8NFU7
HSHSQVPEAGSTTFQ

CEP164

1396

Q9UPV0
DSASPLHHISNGSNT

NTRK2

476

Q16620
LHHISNGSNTPSSSE

NTRK2

481

Q16620
SSFQNHETTHTGEKP

ZNF823

456

P16415
GSHSSTNSPVHKQPS

UBN2

1101

Q6ZU65
SSFSQHERTHTGEKP

ZNF135

311

P52742
HSSGQENTVKNPTHV

RLF

1731

Q13129
TKAHTSAQAQTHSPP

SPEM3

296

A0A1B0GUW6
SLHSHNGSPLTSKNA

SCN10A

441

Q9Y5Y9
SGEEPHSSSSKHIQA

ZNF551

201

Q7Z340
HHQSQSSGTTADKAP

ZNF646

976

O15015
SNLNKHQTTHTGDKP

ZNF585B

731

Q52M93
SSKQSSNRPAHNISH

USF3

2221

Q68DE3
SGKQHQETSACDSPH

TACC2

1596

O95359
SNLNKHQTTHTGDKP

ZNF585A

731

Q6P3V2
SSLAIHQATHSGEKP

ZNF347

386

Q96SE7
SNLSTHQGTHSGEKP

ZNF717

771

Q9BY31
NHVEKSVNHGSSVSP

ZNF415

211

Q09FC8
HPSHTSGQINSAQTS

TET2

266

Q6N021
SSGNVHHCFSSSPNE

PMP22

46

Q01453
DSPPKHAGNNESHSS

PTDSS1

441

P48651
SSLTNHQSTHTGEKP

ZNF181

306

Q2M3W8
NTVDHSHSTTVEKPN

ZFYVE16

911

Q7Z3T8
TGATSANAPNSGSHK

ZNF114

281

Q8NC26
ANAPNSGSHKSHCTG

ZNF114

286

Q8NC26
QESTTFHSNPGSTHT

MUC12

1076

Q9UKN1
QGESTAFQTHPASTH

MUC12

1131

Q9UKN1
GHSEKSTIFHSSPDA

MUC12

2741

Q9UKN1
QGESTAFQTHPASTH

MUC12

3771

Q9UKN1